Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Giant Leap in Global Cancer Vaccines Market

Dec 06, 2011
Share |
 
According to our new research report, Global Vaccine Market Forecast to 2013”, vaccines have emerged as one of the key measures for the prevention of several life-threatening diseases worldwide. Backed by factors, such as huge potential in emerging countries and significant increase in the incidences of life-threatening diseases, the global vaccine market reached the mark of US$ 25.3 Billion in 2010. In future, among all the key market segments, cancer vaccines, influenza vaccines, and pneumococcal vaccines are expected to perform relatively well compared to the others.
 
Our report revealed the key untapped market opportunities in cancer vaccines that still pose to be relatively a new approach to prevent cancer. Some of the popular prophylactic cancer vaccines, such as Gardasil by Merck and Cervarix by GSK are indicated for certain types of cancer-causing human papillomavirus (HPV). With the approval of Provenge (developed by Dendreon), which is indicated for the treatment of advanced prostate cancer, the cancer vaccine market is likely to witness a significant growth and is expected to reach the mark of US$ 3.3 Billion by the end of 2013.
 
The report, Global Vaccine Market Forecast to 2013”, also provides a comprehensive analysis of almost all the key aspects of the global vaccine market. It presents an in-depth analysis of the key market drivers. The report investigates the current market trends and analyzes their impact on the present and future performance of the overall market. While compiling data in the report, the whole market is divided into two key segments: pediatric vaccines and adult vaccines, and accordingly a prudent analysis on key vaccines under each head have been provided.
 
The report is an outcome of an extensive research and proper insight of the global vaccine market that covers information on current market size, products overview, and details of market players in key regions of the world. It also provides a brief overview of recent developments. Forecasts in key sections of the report make use of effective methods and techniques so that future outlook may seem more realistic. Overall, the report is meant to provide clients with an optimum source of knowledge and statistics on global vaccine market.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM357.htm
 
Some of our Related Reports are: 
 
            - Global Influenza Vaccine Market Forecast
            - Global Vaccine Market Forecast to 2012
            - US Glucose Monitoring Market Analysis
            - UAE Healthcare Sector Forecast to 2012
            - Booming Biotech Market in India 
 

Related Press Releases:
» Global Influenza Vaccine Market to Cross US$ 4 Billion Mark by 2011 End
» India and China to Drive Global Vaccine Market
» Emerging Countries Boosting Global Vaccine Market
» Seasonal Influenza Vaccine Market Set to Grow in Near Future
» Cancer Vaccine Market to See Incessant Growth
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports